NSEGeneral Updates7 Oct 2026 · 7 Oct 2026, 03:09 pm
General Updates
Aarey Drugs & Pharmaceuticals Limited · AAREYDRUGS
✦ AI SummaryFundraise
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about the allotment of 11,50,000 Equity Shares pursuant to Conversion of Warrants. The company has approved the allotment of equity shares upon receipt of Rs. 47.85/- per warrant, aggregating to Rs. 5,50,27,500/- to the persons belonging to both promoter and non-promoter Category.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
AAREYDRUGS_07102026150905_BM_OUTCOME-_SIGNED.pdf
View document text
30-10-2026
To, To,
National Stock Exchange of India Ltd., Listing Operation,
Exchange Plaza, C -1, Block G, BSE Limited,
Bandra Kurla Complex, 20th Floor, P.J.Towers,
Bandra (E) , Mumbai – 400 051 Dalal Street, Mumbai – 400 001.
Sub: Outcome for the Board Meeting held on 30-09-2026 at 11.30 AM and Concluded at 02.30
PM Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation s,
2015 for allotment of 11,50,000 Equity Shares pursuant to Conversion of Warrants.
Dear Sir/Madam,
This is with reference to allotment of 50,00,000 Converti ble Warrants of Face Value Rs. 10 /-
Each on Preferential allotment basis at an Offer Price of Rs. 63.80 /- Each and pursuant to
members’ approval dated January 02, 2025 the Board of Directors of the Company at its
meeting held i.e. 30-09-2026 at 11.30 AM and Concluded at 02.30 PM have approved the
allotment of 11,50,000 Equity Shares of Rs. 10 /- each pursuant to Conversion of Fully
Convertible Equity Share Warrants ("Warrants") upon receipt of Rs. 47.85/- per warrant
(being 75% of the issue price i.e. Rs. 63.80/ - Per Warrant } aggregating to Rs. 5,50,27,500/-
to the persons belonging to both promoter and non -promoter Category.
Pursuant to the above allotment, the issued and paid -up capital of the Company shall be as
under:
Particulars Before Allotment After Allotment in Board After Allotment in Board
Meeting 06-08-2026 Meeting 30-09-2026
No. of Value No. of Value No. of Value
Shares (FV Rs. 10 /-) Shares (FV Rs. 10 /-) Shares (FV Rs. 10 /-)
Issued 28354303 Rs. 28354303 0/- 30724303 Rs.307243030 31874303 Rs. 318743030/-
Capital
Paid-up 28354303 Rs. 28354303 0/- 30724303 Rs. 307243030 31874303 Rs. 318743030/-
Capital
Pursuant to Regulation 30 and Schedule III of the Listing Regulations, read with the SEBI
Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (“SEBI Disclosure
Circular”), the detailed disclosure in respect of the allotment of equity shares pu rsuant to
conversion of warrants is set out below at Annexure -A.
Furthermore, read with the outcome of Board Meeting 06 -08-2026 please find enclosed
revised Annexure I table.
Start Time: 11:30 AM
End Time: 02:30 PM
Thanking You
Yours faithfully,
FOR AAREY DRUGS AND PHARMACEUTICALS LIMITED
NIMIT GHATALIA
DIRECTOR
DIN: 07069841
Encl .: As Above
ANNEXURE A
SR. PARTICULARS OF SECURITIES DETAILS
a. Type of Securities Issued Equity Shares issued upon exercise of the convertible
warrants
b. Type of Issue Equity shares issued upon exercise of the Convertible
Warrants which were issued by way of a preferential
allotment.
c. Issue Price Rs. 63.80 /- per warrant (at Premium of Rs. 53.80 /-) as
determined in accordance with Chapter V of the Securities
and Exchange Board of India (Issue of Capital and
Disclosure Requirements) Regulations, 2018 ("SEBI ICDR
Regulations")
d. In case of preferential issue, the listed entity shall disclose the following additional details
to the stock exchange(s): -
1. Name of Investors and their As Per Annexure I & Annexure II
corresponding subscription of
No. of Warrants
2. In case of convertibles - Exercise of 50,00,000 fully convertible warrants into
intimation on conversion of 50,00,000 fully paid-up Equity Shares of the Company of
securities or on lapse of the FV Rs. 10 /- Each.
tenure of the instrument;
Tenure for Conversion into Equity Shares is 18 months
from the date of allotment i.e. 23 -05-2025.
1. 23,70,000 Convertible Warrants Converted into Equity
Shares in the Board Meeting held on 06 -08-2026.
2. 11,50,000 Convertible Warrants Converted into Equity
Share s in the Board Meeting held on 30 -09-2026
3. 14,80,000 Convertible Warrants Outstanding for
Conversion into Equity Shares within 18 Months from
date of allotment i.e. 23 -05-2025.
Annexure I:
List of Allottees to whom Equity Shares are Allotted pursuant to Conversion of Warrants
as on 06 -08-2026:
Sr. No. Name Pre- Pre No. Of No. Of Post Post Category
holding holding warrants Warrants allotment holding %
% Allotted Converted holding
on 23- into
05-2025 Equity
Bina Promoter &
1 Rajesh 4003584 14.12% 500000 500000 4503584 14.66% Promoter
Ghatalia Group
Mihir Promoter &
2 Rajesh 2835888 10.00% 345000 345000 3180888 10.35% Promoter
Ghatalia Group
Nimit Promoter &
3 Rajesh 1150000 4.06% 500000 350000 1500000 4.88% Promoter
Ghatalia Group
Promoter &
Mira Mihir
4 690000 2.43% 250000 250000 940000 3.06% Promoter
Ghatalia
Group
Promoter &
Ekta Nimit
5 0 0.00% 500000 500000 500000 1.63% Promoter
Ghatalia
Group
Mihir
Promoter &
Rajesh
6 0 0.00% 245000 245000 245000 0.80% Promoter
Ghatalia
Group
(HUF)
Rajesh Promoter &
7 Pranlal 2,971 0.01% 180000 180000 182971 0.60% Promoter
Ghatalia Group
Enam
Promoter &
Organics
8 0 0.00% 345000 0 0 0.00% Promoter
India
Group
Limited
Sr. No. Name Pre- Pre No. Of No. Of Post Post Category
holding holding warrants Warrants allotment holding %
% Allotted Converted holding
on 23- into
05-2025 Equity
Nimit
Promoter &
Impex
9 2010000 7.09% 345000 0 2010000 6.54% Promoter
Private
Group
Limited
Suraj
Promoter &
Tradelinks
10 0 0.00% 345000 0 0 0.00% Promoter
Private
Group
Limited
Worth
Investment
Promoter &
11 0 0.00% 345000 0 0 0.00% Promoter
Trading
Group
Company
Limited
Archana
12 Pramod 0 0.00% 200000 0 0 0.00% Public
Wani
Priti
13 Vijaykumar 0 0.00% 500000 0 0 0.00% Public
Shah
Vaishali
14 0 0.00% 250000 0 0 0.00% Public
Aggarwal
Mamta
15 Girish 500 0.00% 100000 0 500 0.00% Public
Chheda
Sujata
16 Tushar 0 0.00% 25000 0 0 0.00% Public
Mehta
Tushar
17 0 0.00% 25000 0 0 0.00% Public
Mehta Huf
Annexure I:
List of Allottees to whom Equity Shares are Allotted pursuant to Conversion of Warrants as
on 30-09-2026:
Sr. Name Pre- Pre No. Of No. Of Post Post Category
No. holding holding % warrants Warrants allotment holding
Outstanding Converted holding %
to be into
Converted Equity 30-
before 30- 09-2026
09-2026
1 Bina Rajesh Promoter &
Ghatalia 4503584 14.66% 0 0 4503584 14.13% Promoter
Group
2 Mihir Rajesh Promoter &
Ghatalia 3180888 10.35% 0 0 3180888 9.98% Promoter
Group
3 Nimit Rajesh Promoter &
Ghatalia 1500000 4.88% 150000 150000 1650000 5.18% Promoter
Group
4 Mira Mihir Promoter &
Ghatalia 940000 3.06% 0 0 940000 2.95% Promoter
Group
5 Ekta Nimit Promoter &
Ghatalia 500000 1.63% 0 0 500000 1.57% Promoter
Group
6 Mihir Rajesh Promoter &
Ghatalia 245000 0.80% 0 0 245000 0.77% Promoter
(HUF) Group
7 Rajesh Promoter &
Pranlal 182971 0.60% 0 0 182971 0.57% Promoter
Ghatalia Group
8 Enam Promoter &
Organics 0 0.00% 345000 0 0 0.00% Promoter
India Limited Group
9 Nimit Impex Promoter &
Private 2010000 6.54% 345000 0 2010000 6.31% Promoter
Limited Group
Sr. Name Pre- Pre No. Of No. Of Post Post Category
No. holding holding % warrants Warrants allotment holding
Outstanding Converted holding %
to be into
Converted Equity 30-
before 30- 09-2026
09-2026
10 Suraj
Promoter &
Tradelinks
0 0.00% 345000 0 0 0.00% Promoter
Private
Group
Limited
11 Worth
Investment Promoter &
and Trading 0 0.00% 345000 0 0 0.00% Promoter
Company Group
Limited
12 Archana
Pramod 0 0.00% 200000 200000 200000 0.63% Public
Wani
13 Priti
Vijaykumar 0 0.00% 500000 500000 500000 1.57% Public
Shah
14 Vaishali
0 0.00% 250000 250000 250000 0.78% Public
Aggarwal
15 Mamta
Girish 500 0.00% 100000 0 500 0.00% Public
Chheda
16 Sujata
Tushar 0 0.00% 25000 25000 25000 0.08% Public
Mehta
17 Tushar
0 0.00% 25000 25000 25000 0.08% Public
Mehta Huf
FOR AAREY DRUGS AND PHARMACEUTICALS LIMITED
NIMIT GHATALIA
DIRECTOR
DIN:07069841